The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor flare reactions secondary to T-cell engaging immunotherapies: A study from the French REISAMIC registry.
 
Alexandre Xu-Vuillard
No Relationships to Disclose
 
Matthieu Roulleaux Dugage
No Relationships to Disclose
 
Thomas Hueso
No Relationships to Disclose
 
Antoine Hollebecque
Honoraria - Amgen; BMS; Eisai; Incyte; MSD Oncology; Relay Therapeutics; SERVIER
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca/MedImmune (Inst); Debiopharm Group (Inst); Gritstone Bio; Incyte (Inst); Lilly (Inst); QED therapeutics; Relay Therapeutics; Sanofi; Spectrum Pharmaceuticals (Inst); Taiho Oncology; Taiho Pharmaceutical
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca/MedImmune; Incyte; Lilly; Pierre Fabre; Roche; SERVIER
Other Relationship - Abbvie; Agios; Amgen; argenx; Arno Therapeutics; Astex Pharmaceuticals; AstraZeneca; AVEO; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Chugai Pharma; Clovis Oncology; Daiichi Sankyo; Debiopharm Group; Eisai; Exelixis; FORMA Therapeutics; GamaMabs Pharma; Genentech; GlaxoSmithKline; H3 Biomedicine; Innate Pharma; Janssen-Cilag; Kyowa Hakko Kirin; Lilly; Loxo; Lytix Biopharma; MedImmune; Menarini; Merck Sharp & Dohme; Merrimack; Merus; Millenium Pharamceuticals; Nanobiotix; Nektar; Novartis; Octimet; Oncoethix; Onyx; Orion; Oryzon Genomics; Pfizer; Pierre Fabre; Roche; Roche/Genentech; Sanofi/Aventis; SERVIER; Taiho Pharmaceutical; Tesaro; Xencor
 
Karim Fizazi
Honoraria - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Novartis (Inst)
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo Europe GmbH (Inst); Janssen Oncology (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Janssen; MSD; Novartis; Pfizer
 
Anas Gazzah
No Relationships to Disclose
 
Rastislav Bahleda
No Relationships to Disclose
 
Capucine Baldini
Consulting or Advisory Role - Bicycle Therapeutics; Janssen Oncology; Janssen Oncology; Rising Tide Foundation
Research Funding - Foundation BMS (Inst); Foundation BMS (Inst)
Expert Testimony - Abbvie; AstraZeneca; Bristol-Myers Squibb; MSD Oncology; MSD Oncology
Travel, Accommodations, Expenses - Amgen; Janssen Oncology; MSD Oncology; Roche/Genentech
 
Eric Deutsch
Stock and Other Ownership Interests - Graegis Pharmaceuticals
Honoraria - Graegis Pharmaceuticals
Consulting or Advisory Role - Graegis Pharmaceuticals
Research Funding - AstraZeneca/Merck; BMSi; Boehringer Pharma GmbH; MSD; Roche; SERVIER
 
Vincent Ribrag
Employment - PEGASCY
Consulting or Advisory Role - AstraZeneca/UK
Speakers' Bureau - Abbvie; BeiGene; Ipsen
Research Funding - Astex Pharmaceuticals; GlaxoSmithKline
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Cristina Smolenschi
Consulting or Advisory Role - BMSi; Merck Serono; Pierre Fabre
Travel, Accommodations, Expenses - Pierre Fabre
 
Judith Michels
Consulting or Advisory Role - GlaxoSmithKline; Regeneron Pharmaceuticals, Inc.;
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Merck
 
Veronique Minard
Honoraria - Abbvie; BMSi; Roche; Sanofi
Consulting or Advisory Role - Abbvie; BMSi; Roche; Sanofi
Speakers' Bureau - Abbvie; BMSi; Roche; Sanofi
 
Sabine Messayke
No Relationships to Disclose
 
Benjamin Besse
Honoraria - Abbvie (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Lilly (Inst); MSD (Inst); OSE Immunotherapeutics (Inst); Sanofi/Aventis (Inst); SERVIER (Inst)
Consulting or Advisory Role - Abbvie (Inst); beijin avistone (Inst); BioNTech SE (Inst); Bristol-Myers Squibb (Inst); CureVac (Inst); Ellipses Pharma (Inst); F. Hoffmann LaRoche (Inst); Foghorn Therapeutics (Inst); Immunocore (Inst); Lilly (Inst); Owkin (Inst); PharmaMar (Inst); Regeneron (Inst); Sanofi/Aventis (Inst)
Research Funding - Amgen (Inst); Anheart Therapeutics (Inst); AstraZeneca (Inst); BeiGene (Inst); CureVac (Inst); Daiichi Sankyo Europe GmbH (Inst); Enliven Therapeutics (Inst); Genmab (Inst); Janssen (Inst); Lilly (Inst); MSD (Inst); OSE Immunotherapeutics (Inst); PharmaMar (Inst); Prelude Therapeutics (Inst); Sanofi (Inst); Takeda (Inst)
 
Olivier Lambotte
No Relationships to Disclose
 
Christophe Massard
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Blueprint Medicines; BMS; Celgene; Debiopharm Group; Faron Pharmaceuticals; Faron Pharmaceuticals; Faron Pharmaceuticals; Faron Pharmaceuticals; Faron Pharmaceuticals; Genentech/Roche; INNATE PHARMA; IPSEN; Janssen; Lilly; MSD; Novartis; ORION; Pfizer; PharmaMar; Sanofi; Taiho Pharmaceutical
 
Aurelien Marabelle
Stock and Other Ownership Interests - Adagene; Centessa Pharmaceuticals; Deka Biosciences; HiFiBiO Therapeutics; HotSpot Therapeutics; Lytix Biopharma; Marengo Therapeutics; Shattuck Labs
Honoraria - ESMO; European Journal of Cancer; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Adagene; Andera; Asgard Therapeutics; Centessa Pharmaceuticals; Daiichi Sankyo Europe GmbH; Deka Biosciences; Grey Wolf Therapeutics; Guidepoint Global; HiFiBiO Therapeutics; Hotspot Therapeutics; ImCheck therapeutics; Innate Pharma; Johnson & Johnson/Janssen; Lytix Biopharma; Medicxi; MSD; Pathios Therapeutics; Pegaone; Pierre Fabre
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Transgene (Inst)
Patents, Royalties, Other Intellectual Property - monoclonal antibodies against CD81 (Stanford University)
Travel, Accommodations, Expenses - HiFiBiO Therapeutics; Marengo Therapeutics; Pathios Therapeutics
Other Relationship - Elsevier
 
Kaïssa Ouali
Consulting or Advisory Role - Amgen; Anaveon; Sotio
Travel, Accommodations, Expenses - Amgen; Eisai; Sotio
 
Jean-Marie Michot
Consulting or Advisory Role - Bristol-Myers Squibb; IDEOGEN; Mallinckrodt/Therakos; Regeneron
Research Funding - Astex Pharmaceuticals (Inst); GlaxoSmithKline (Inst)
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Cellgen